血管通路手术的技术革新:对两项最新进展的反思

IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES
A. Williamson
{"title":"血管通路手术的技术革新:对两项最新进展的反思","authors":"A. Williamson","doi":"10.1136/bmjinnov-2021-000854","DOIUrl":null,"url":null,"abstract":"© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION The discipline of vascular access surgery can be defined as the facilitation of dialysis through rapid and easy access to a patient’s bloodstream. 2 This is one of the most fundamental diagnostic and therapeutic principles in the care of renal failure patients; however, instruments to achieve this in a controlled manner were only developed midway through the 17th century. By the early 20th century, the earliest dialysis machines had been created; however, haemodialysis could not continue beyond a couple of dozen treatments per patient—there was an exhaustion of access as the blood vessels would be ligated (‘tiedoff ’) after each treatment to prevent excessive bleeding. Modern vascular access methods were born in the 1950s when the first central venous catheters (CVCs—catheter entering a central vein), arteriovenous grafts (AVG—a synthetic tube connecting an artery and a vein) and native arteriovenous fistulas (AVF—a surgically created communication between an artery and a vein) were used. Technological advancement in these early stages focused on vascular anastomosis techniques and arteriovenous shunting (directing arterial blood through the venous system) materials to overcome access failure and thrombosis, respectively. The need for innovation to overcome the shortcomings of previous technologies or practices is an ongoing process—this report describes the driving forces behind two recent developments in the field of vascular access and evaluates their advantages and disadvantages against alternate technologies and their current use in clinical practice: ► The Hemodialysis Reliable Outflow (HeRO) graft—a twocomponent graft aiming to overcome the problem of central venous stenosis (luminal narrowing of the central veins). ► Percutaneous endovascular fistula creation—imageguided fistula creation aiming to avoid complications associated with open surgically created AVFs.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"84 1","pages":"291 - 295"},"PeriodicalIF":1.4000,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Technological innovation in vascular access surgery: a reflection on two recent developments\",\"authors\":\"A. Williamson\",\"doi\":\"10.1136/bmjinnov-2021-000854\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION The discipline of vascular access surgery can be defined as the facilitation of dialysis through rapid and easy access to a patient’s bloodstream. 2 This is one of the most fundamental diagnostic and therapeutic principles in the care of renal failure patients; however, instruments to achieve this in a controlled manner were only developed midway through the 17th century. By the early 20th century, the earliest dialysis machines had been created; however, haemodialysis could not continue beyond a couple of dozen treatments per patient—there was an exhaustion of access as the blood vessels would be ligated (‘tiedoff ’) after each treatment to prevent excessive bleeding. Modern vascular access methods were born in the 1950s when the first central venous catheters (CVCs—catheter entering a central vein), arteriovenous grafts (AVG—a synthetic tube connecting an artery and a vein) and native arteriovenous fistulas (AVF—a surgically created communication between an artery and a vein) were used. Technological advancement in these early stages focused on vascular anastomosis techniques and arteriovenous shunting (directing arterial blood through the venous system) materials to overcome access failure and thrombosis, respectively. The need for innovation to overcome the shortcomings of previous technologies or practices is an ongoing process—this report describes the driving forces behind two recent developments in the field of vascular access and evaluates their advantages and disadvantages against alternate technologies and their current use in clinical practice: ► The Hemodialysis Reliable Outflow (HeRO) graft—a twocomponent graft aiming to overcome the problem of central venous stenosis (luminal narrowing of the central veins). ► Percutaneous endovascular fistula creation—imageguided fistula creation aiming to avoid complications associated with open surgically created AVFs.\",\"PeriodicalId\":53454,\"journal\":{\"name\":\"BMJ Innovations\",\"volume\":\"84 1\",\"pages\":\"291 - 295\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2022-06-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ Innovations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjinnov-2021-000854\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Innovations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjinnov-2021-000854","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

©作者(或其雇主)2022。禁止商业重用。请参阅权利和权限。英国医学杂志出版。血管通路手术的学科可以被定义为通过快速和容易地进入病人的血液来促进透析。这是肾衰竭患者护理中最基本的诊断和治疗原则之一;然而,以一种可控的方式实现这一目标的仪器直到17世纪中期才被开发出来。到20世纪初,最早的透析机已经制造出来;然而,血液透析不能在每个病人进行几十次以上的治疗,因为每次治疗后血管都会被结扎(“捆扎”),以防止过度出血,因此血液透析的途径会耗尽。现代血管通路方法诞生于20世纪50年代,当时首次使用了中心静脉导管(cvc -进入中心静脉的导管)、动静脉移植物(avg -连接动脉和静脉的合成管)和原生动静脉瘘(avf -手术创建的动脉和静脉之间的通信)。这些早期阶段的技术进步分别集中在血管吻合技术和动静脉分流(通过静脉系统引导动脉血液)材料上,以克服通路失败和血栓形成。需要创新来克服以前技术或实践的缺点是一个持续的过程——本报告描述了血管通路领域两项最新发展背后的驱动力,并评估了它们相对于替代技术的优缺点及其目前在临床实践中的应用:血液透析可靠流出(HeRO)移植物-一种双组分移植物,旨在克服中心静脉狭窄(中心静脉管腔狭窄)的问题。经皮血管内造瘘术——影像引导下造瘘术旨在避免开放性手术造瘘的并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Technological innovation in vascular access surgery: a reflection on two recent developments
© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION The discipline of vascular access surgery can be defined as the facilitation of dialysis through rapid and easy access to a patient’s bloodstream. 2 This is one of the most fundamental diagnostic and therapeutic principles in the care of renal failure patients; however, instruments to achieve this in a controlled manner were only developed midway through the 17th century. By the early 20th century, the earliest dialysis machines had been created; however, haemodialysis could not continue beyond a couple of dozen treatments per patient—there was an exhaustion of access as the blood vessels would be ligated (‘tiedoff ’) after each treatment to prevent excessive bleeding. Modern vascular access methods were born in the 1950s when the first central venous catheters (CVCs—catheter entering a central vein), arteriovenous grafts (AVG—a synthetic tube connecting an artery and a vein) and native arteriovenous fistulas (AVF—a surgically created communication between an artery and a vein) were used. Technological advancement in these early stages focused on vascular anastomosis techniques and arteriovenous shunting (directing arterial blood through the venous system) materials to overcome access failure and thrombosis, respectively. The need for innovation to overcome the shortcomings of previous technologies or practices is an ongoing process—this report describes the driving forces behind two recent developments in the field of vascular access and evaluates their advantages and disadvantages against alternate technologies and their current use in clinical practice: ► The Hemodialysis Reliable Outflow (HeRO) graft—a twocomponent graft aiming to overcome the problem of central venous stenosis (luminal narrowing of the central veins). ► Percutaneous endovascular fistula creation—imageguided fistula creation aiming to avoid complications associated with open surgically created AVFs.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
BMJ Innovations
BMJ Innovations Medicine-Medicine (all)
CiteScore
4.20
自引率
0.00%
发文量
63
期刊介绍: Healthcare is undergoing a revolution and novel medical technologies are being developed to treat patients in better and faster ways. Mobile revolution has put a handheld computer in pockets of billions and we are ushering in an era of mHealth. In developed and developing world alike healthcare costs are a concern and frugal innovations are being promoted for bringing down the costs of healthcare. BMJ Innovations aims to promote innovative research which creates new, cost-effective medical devices, technologies, processes and systems that improve patient care, with particular focus on the needs of patients, physicians, and the health care industry as a whole and act as a platform to catalyse and seed more innovations. Submissions to BMJ Innovations will be considered from all clinical areas of medicine along with business and process innovations that make healthcare accessible and affordable. Submissions from groups of investigators engaged in international collaborations are especially encouraged. The broad areas of innovations that this journal aims to chronicle include but are not limited to: Medical devices, mHealth and wearable health technologies, Assistive technologies, Diagnostics, Health IT, systems and process innovation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信